ISRCTN ISRCTN58932628
DOI https://doi.org/10.1186/ISRCTN58932628
Secondary identifying numbers NL20031.068.07
Submission date
21/03/2011
Registration date
28/07/2011
Last edited
28/07/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Martijn Poeze
Scientific

Department of Surgery
P. Debyelaan 25
PO Box 5800
Maastricht
6226 BV
Netherlands

Study information

Study designProspective randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleProspective randomized controlled trial comparing tape versus semi-rigid brace treatment of patients with grade II and III ankle ligament rupture
Study acronymTAPELOC
Study objectivesTreatment of lateral ankle sprain with a semi-rigid brace leads to less local complications and more patient satisfaction than treatment with tape. Reduction in complications will improve patient satisfaction with the treatment method and this will improve functional outcome by enhancing compliance with the treatment method used.
Ethics approval(s)Maastricht University Medical Center Ethical Committee, 03 December 2007, ref: MEC07-2-094
Health condition(s) or problem(s) studiedAnkle distortion, ankle ligament rupture
Intervention1. Tape treatment: after randomisation tape immobilisation is started 5-8 days after initial treatment with immobilisation using bandage
2. Taping is performed by a select group of experienced and skilled healthcare professionals of the outpatient clinic
3. The tape consists of three layers
4. The first layer is a latex free, adhesive, bandage to protect the skin (Coban, 3M)
5. The second layer consists of 2.5cm non-elastic strapping tape (Leukotape, Beiersdorff) used for support
6. The third layer consists of Elastoplasts 6cm broad, elastic used for fixation of the second layer (BDF, Beiersdorf)
7. This taping is applied twice with two weeks interval
8. The other group is treated with a semi-rigid brace (AirLoc ® Bauerfeind, Zeulenroda, Germany)
9. After instructions to the patient how to reapply the brace, revision of these instructions is made after 2 weeks
10. Total duration of both treatment is 4 weeks
11. Follow-up duration is 12 weeks after randomization
Intervention typeOther
Primary outcome measure1. Patient satisfaction is assessed by verbal rating scale: poor (5), moderate (4), sufficient (3), good (2) and excellent (1) both at 2 and 4 weeks after start of the study treatment
2. Level of pain is evaluated using the visual analogue scale at baseline, 2, 4, 8 and 12 weeks
3. Ankle joint function is assessed using the validated Karlsson scoring scale at 2, 4, 8 and 12 weeks after start of the study treatment
4. Range of motion is measured using an electronic goniometer at 2, 4, 8 and 12 weeks after start of the study treatment
Secondary outcome measuresAny complications of the treatments
Overall study start date01/01/2008
Completion date31/12/2011

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants100
Key inclusion criteriaPatients were included if they sustained a grade II or III ankle sprain (significant damage to lateral ligaments defined by the presence of a lateral hematoma and tenderness at the anterior lateral ligament without or with instability) and were presented in the outpatient clinic within 5-7 days.
Key exclusion criteria1. Fracture
2. Age was under 16 or over 55 years
3. If they had experienced a previous ankle sprain or fracture
4. If they sustained swelling that makes tape treatment impossible
Date of first enrolment01/01/2008
Date of final enrolment31/12/2011

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Department of Surgery
Maastricht
6226 BV
Netherlands

Sponsor information

Maastricht University Medical Center (Netherlabnds)
University/education

c/o Prof. Peter R.G. Brink
Department of Surgery
P. Debyelaan 25
PO Box 5800
Maastricht
6226 BV
Netherlands

Website http://www.maastrichtuniversity.nl/
ROR logo "ROR" https://ror.org/02d9ce178

Funders

Funder type

Hospital/treatment centre

Maastricht University Medical Center (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan